Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
02/2012
02/14/2012US8114838 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2
02/14/2012US8114837 Method for inhibiting postprandial rise in blood glucose by administering κ-casein
02/14/2012US8114836 Long-acting veterinary polypeptides and methods of producing and administering same
02/14/2012US8114835 Microtexture matrix comprising diacetylene conjugated amino acid sequences for use in propagation of preferential tissues; drug screening
02/14/2012US8114834 Self-assembling peptide amphiphiles
02/14/2012US8114833 Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
02/14/2012US8114832 Conformational altered protein; contacting with drug capable of binding; forming fusion protein; detection; side effect reduction
02/14/2012US8114831 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
02/14/2012US8114830 Polypeptoid pulmonary surfactants
02/14/2012US8114657 Antimicrobial protein compositions and production thereof from marine bacteria
02/14/2012US8114648 immunizing a subject with a sufficient amount of a translated polypeptide to produce antibody; containing a phenylalanine or tyrosine derivative analoges
02/14/2012US8114607 Type IV collagen-like immunoreactive peptide
02/14/2012US8114603 collecting a blood sample from the subject; andmeasuring the levels of Triggering Receptor Expressed on Myeloid cells (TREM-1) splice variant protein in sample, a decrease in the levels of TREM-1 splice variant indicates an inflammatory response
02/14/2012US8114586 Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopes
02/14/2012US8114443 Phytase-expressing transgenic plants
02/14/2012US8114441 Immune stimulatory infant nutrition
02/14/2012US8114439 Synthetic peptides reducing or removing bags formed under the lower eye contour and their use in cosmetic or dermopharmaceutical compositions
02/14/2012US8114437 Solvent/polymer solutions as suspension vehicles
02/14/2012US8114431 Biomolecular coating for implants
02/14/2012US8114428 Methods for manufacturing a composition for treating bone and/or cartilage defects
02/14/2012US8114427 Biologically active implants
02/14/2012US8114419 Nucleic acid compositions for stimulating immune responses
02/14/2012US8114412 T. cruzi-derived neurotrophic agents and methods of use therefor
02/14/2012US8114407 Tyrosine kinase receptor epitope for use in identifying modulators for prevention and treatment of renal cancer
02/14/2012US8114404 Method and composition for altering a B cell mediated pathology
02/14/2012US8114401 Chlamydia trachomatis antigens
02/14/2012US8114399 Targeting VEGF-B regulation of fatty acid transporters to modulate human diseases
02/14/2012US8114398 EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart disease
02/14/2012US8114395 Treatment of viral diseases with recombinant interferon α
02/14/2012US8114394 Use of IL-1 antagonists to treat gout
02/14/2012CA2570406C Use of botulinum toxin for treating pelvic pain
02/14/2012CA2522179C Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles
02/14/2012CA2402160C Heparinase iii and uses thereof
02/09/2012WO2012019184A2 Compositions and methods for detecting, diagnosing, and treating cancer
02/09/2012WO2012019178A2 Methods of treating and diagnosing acute chest syndrome
02/09/2012WO2012018907A2 Polypeptides for treating and/or limiting influenza infection
02/09/2012WO2012018877A2 Treating breast cancer with anti-il-19 antibody
02/09/2012WO2012018866A2 Methods and compositions for the diagnosis and treatment of breast cancer
02/09/2012WO2012018616A2 Polypeptides that bind trail-r1 and trail-r2
02/09/2012WO2012018594A2 Plant-derived polysaccharides for delivery of rna-based therapies
02/09/2012WO2012018260A1 Epidermal growth factor receptor targeted immune therapy
02/09/2012WO2012018145A2 Agent for improving quality of life
02/09/2012WO2012017439A2 Methods of treating autoimmune diseases of the central nervous system (cns) and neurodegenerative diseases
02/09/2012WO2012017391A2 Novel compounds as dpp-iv inhibitors and process for preparation thereof
02/09/2012WO2012017367A1 Composition comprising glutathione reductase and oxidized glutathione, and therapeutic uses thereof
02/09/2012WO2012017310A2 Protein fusion constructs possessing thrombolytic and anticoagulant properties
02/09/2012WO2012017123A1 Method for producing limited and extensive protein hydrolyzates from agroindustrial waste.
02/09/2012WO2012017085A1 Antibodies against 6-sulfo-lacnac-positive human dendritic cells, and their use
02/09/2012WO2012017058A1 Improved recombinant human follicle-stimulating hormone
02/09/2012WO2012016918A1 Use of a peptide enhancing the ability of radiation therapy to kill cancer cells
02/09/2012WO2012016576A1 Improved recombinant human follicle-stimulating hormone
02/09/2012WO2012016419A1 Glp-1 derivatives and uses thereof
02/09/2012WO2012016362A1 Β-secretase inhibitors for treating alzheimer's disease and uses thereof
02/09/2012WO2011153430A3 Inhibiting striated muscle activator of rho signaling (stars) to improve glycemic control
02/09/2012US20120036599 Novel fungal enzymes
02/09/2012US20120035117 Process for Synthesis of Cyclic Octapeptide
02/09/2012US20120035116 Bile acids and biguanides as protease inhibitors for preserving the integrity of peptides in the gut
02/09/2012US20120035115 Chemical modifications of monomers and oligonucleotides with cycloaddition
02/09/2012US20120035114 Inhibitors of stat3 and uses thereof
02/09/2012US20120035113 Methods of reducing trail-induced apoptosis by trail isoforms
02/09/2012US20120035112 Neuronal differentiation-inducing peptide and use thereof
02/09/2012US20120035111 Therapeutic Application of Adiponectin in Patients with Acute Myocardial Infarction
02/09/2012US20120035110 METHOD OF PRODUCING RECOMBINANT HIGH MOLECULAR WEIGHT vWF IN CELL CULTURE
02/09/2012US20120035109 Follicle stimulating hormone superagonists
02/09/2012US20120035108 Spray base material including low-molecular gelator
02/09/2012US20120035107 Compositions for achieving a therapeutic effect in an anatomical structure
02/09/2012US20120035106 Use of apl-type peptide for treating intestinal inflammatory diseases and type 1 diabetes
02/09/2012US20120035105 Insulin Therapies for the Treatment of Diabetes, Diabetes Related Ailments, and/or Diseases or Conditions Other Than Diabetes or Diabetes Related Ailments
02/09/2012US20120035104 Insulin derivatives
02/09/2012US20120035103 Method for administration of insulin and pharmaceutical composition thereof
02/09/2012US20120035102 Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
02/09/2012US20120035101 Long-acting growth hormone and methods of producing same
02/09/2012US20120035100 Satiation peptide administration
02/09/2012US20120035099 Fgf21 analogues and derivatives
02/09/2012US20120035098 Novel antiviral agent
02/09/2012US20120035097 Methods of treating bacterial infections using oritavancin
02/09/2012US20120035096 Agent for preventing arteriosclerosis, agent for suppressing vascular intimal thickening and agent for improving vascular endothelial function
02/09/2012US20120035095 Orally administered peptides synergize statin activity
02/09/2012US20120035094 F11 receptor (f11r) antagonists as therapeutic agents
02/09/2012US20120035093 Amphiphilic Polymer-Protein Conjugates and Methods of Use Thereof
02/09/2012US20120035073 Compositions and methods for the treatment of immune related diseases
02/09/2012US20120034690 Cell lines producing blocking antibodies to human RANKL
02/09/2012US20120034689 Mycobacterial antigens expressed during latency
02/09/2012US20120034657 Thrombopoietic compounds
02/09/2012US20120034651 Akt activity specifically inhibiting polypeptide
02/09/2012US20120034609 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy
02/09/2012US20120034302 Particulate composition and the method of making the same
02/09/2012US20120034299 Compositions for the treatment of gluten intolerance and uses thereof
02/09/2012US20120034294 Method of making small liposomes
02/09/2012US20120034291 Nanoimprinting of silk fibroin structures for biomedical and biophotonic applications
02/09/2012US20120034277 Resuscitation fluid
02/09/2012US20120034261 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
02/09/2012US20120034251 Pharmaceutical composition for treating or preventing cancer by inducing dendritic cell-like differentiation from monocytes to improve anticancer immune activity
02/09/2012US20120034247 Monomethylvaline compounds capable of conjugation to ligands
02/09/2012US20120034246 Monomethylvaline compounds capable of conjugation to ligands
02/09/2012US20120034242 Cytokine-expressing cellular vaccine combinations
02/09/2012US20120034240 Perlecan as a biomarker for renal dysfunction
02/09/2012US20120034239 Proteins with improved solubility and methods for producing and using same
02/09/2012US20120034222 Nitric Oxide Generating Medical Devices
02/09/2012US20120034219 Uses of il-23 agonists and antagonists; related reagents